MedTrace Logo

Low Dose of Hydrocortisone and Fludrocortisone in Adult Cardiogenic Shock.

NCT03773822 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 380

Last updated 2026-05-19

No results posted yet for this study

Summary

The purpose of this randomized controlled trial is to evaluate the hemodynamic effect of low dose corticosteroid therapy (hydrocortisone and fludrocortisone) in the treatment of adult cardiogenic shock.

Conditions

  • Cardiogenic Shock

Interventions

COMBINATION_PRODUCT

Hydrocortisone + Flucortac

Low dose steroids

OTHER

Placebo

Placebo

Sponsors & Collaborators

  • CMC Ambroise Paré

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-04-19
Primary Completion
2023-04-05
Completion
2023-04-05

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03773822 on ClinicalTrials.gov